Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | IPH6501 |
Trade Name | |
Synonyms | IPH-6501|IPH 6501 |
Drug Descriptions |
IPH6501 is a tetraspecific molecule targeting NKp46, CD16a, IL2RB (CD122), and MS4A1 (CD20), which potentially induces NK cell-mediated cytotoxicity against tumor cells (Blood (2022) 140 (Supplement 1): 11559). |
DrugClasses | CD20 Antibody 24 |
CAS Registry Number | NA |
NCIT ID | NA |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
IPH6501 | IPH6501 | 0 | 1 |